Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
申请公布号
WO2005117858(A2)
申请公布日期
2005.12.15
申请号
WO2005US19111
申请日期
2005.06.01
申请人
MYLAN LABORATORIES, INC.;DAVIS, ERIC;O'DONNELL, JOHN;BOTTINI, PETER, BRUCE